drugset

drugset / Trial / NCT06744816

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

NCT06744816 ↗

Phase 0 Recruiting 20 enrolled M.D. Anderson Cancer Center Averitas Pharma, Inc. · collab

NaSingle-groupOpen-labelSupportive care

Summary

To learn if topical capsaicin can help relieve pain from CIPN and improve gait (the pattern of walking) in patients.

Timeline

Start: 2025-12-11
Primary completion: 2027-11-30
Completion: 2027-11-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capsaicin	Small molecule	8 %	Topical

Indications